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Multiple sclerosis (MS) l is associated with  Ig synthesis inside the blood brain 
barrier (BBB). The Ig is usually IgG1  K, and is allotype- and idiotype-restricted 
(reviewed in  1 and 2). Two-dimensional electrophoresis (2DE) (3) of the L chains 
of cerebrospinal  fluid (CSF) IgG,  IgA,  and  IgM,  as well as of IgA and  IgM H 
chains, has established that,  in many MS patients,  the immune response is truly 
pauciclonal; the IgG response that is quantitatively dominant commonly expresses 
<20 major L chains,  but there are instances where most of the L chain protein 
in  MS CSF is comprised of one or a  few major  L  chains  (4).  In  some central 
nervous  system  disorders,  high  levels  of specific  antibody  are  produced.  In 
subacute sclerosing panencephalitis  (SSPE), as much as  80% of the total  intra- 
BBB-produced lgG may be viral-specific (5), and most or all the oligoclonal IgG 
bands react with viral antigen (6). The Ig-synthesized intra-BBB in MS may also 
be antigen  specific (7).  Furthermore,  persistent  multifocal  and  multiphasic  in- 
flammation  in the MS brain may indicate persistent antigen.  The restrictions of 
MS CSF Ig are also considered indicative of a specific immune response (2). An 
alternative hypothesis, based on IEF spectrotype differences in IgG eluted from 
different  regions  of a  single  MS  brain,  asserts  that  IgG  production  in  MS  is 
nonsense  antibody  (8).  Nonsense  antibody  proposals  have  been  influential  in 
hypotheses implicating  MS as a  disorder of immunoregulation  (9,  10) and  are 
made  more  credible  by the  failure  to  identify  major  antigen  targets  for  the 
immune  response  in  MS.  Whether  MS  CSF  IgG  is  a  nonnsense  or  specific 
antibody is pivotal in  MS research,  since intra-BBB-synthesized IgG, if antigen 
specific,  may  constitute  the  powerful  probe  required  to  isolate  and  identify 
antigen(s) relevant to MS. 
IEF  has  limitations  as a  procedure  for the determination  of the clonal com- 
plexity of immune responses. First, monoclonal Ig may fractionate into multiple 
bands  by  IEF  (1 1).  Second,  a  single  band  may  be clonally  heterogenous  and 
represent  structurally  diverse  Ig  molecules that  cofocus because of shared  pI 
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(12).  Third, human  IgG, and particularly MS CSF IgG is neutral-to-basic in its 
range ofpI, and the resolving power of IEF for basic proteins is limited. Another 
series of problems arises when IEF spectrotype changes are attributed to changes 
in  Ig clonal expression; IEF spectrotype differences may be the result of a  loss 
of particular B cell clones or the emergence of new clones, or Ig may be stable 
at a clonal level while differences in IEF mobility could result from posttransla- 
tional protein modification, including deamidation, differential glycosylation, or 
proteolysis. 2DE has recently (4,  13,  14) been applied to the analysis of Ig from 
several  species.  This  method  is  suitable  for the analysis  of restricted  immune 
responses  and  is  uniquely  useful  for  L  chain  analysis,  since  pI  gradients  that 
encompass the entire pI range of human  L chains are obtainable. Also, L chains 
demonstrate considerable Mr heterogeneity by 2 DE, further enhancing the ability 
to  resolve  structurally  disparate  L  chains.  Because  of the  unique  M,  and  pI 
mobilities of H  chains  of IgM,  IgA,  and  IgG  subclasses,  Ig  H  chains are  also 
readily resolved from each other (14). By immunoblotting, 2DE spots represent- 
ing proteolytic fragments of Ig can also be identified (4). For these reasons, we 
supplement IEF analysis with 2DE and show here that the humoral,  intra-BBB 
immune response in MS, at a clonal level, is profoundly stable over long periods. 
Also,  we  show  that  IgG,  IgA,  and  IgM  isolated from different regions of MS 
brains and  matched CSF are similar.  These results conflict with nonsense anti- 
body  proposals  but  are  consistent  with  allotypic  (15)  and  idiotypic  (16-18) 
analyses, and indicate extraordinary molecular uniformity and temporal persist- 
ence of the Ig response in MS. 
Materials and Methods 
Patients.  CSF from normal persons and patients with MS, and normal and MS brain 
tissue were obtained from the National Neurological Research Bank, Los Angeles, CA. 
Tissues and body fluids were stored at -70°C, and in most cases were thawed once before 
analysis.  Patients were chosen for analysis  on the basis  of availability of CSF (and sera) 
from individual patients over long intervals of disease, and included patients in various 
stages of disease with varying severity of disability; the CSF IgG concentrations ranged 
from 2.0 to 25 mg/dl. 
lsoelectric Focusing.  Native IEF of IgG and IgA was performed using polyacrylamide- 
IEF gels (LKB Instruments, Inc., Gaithersburg, MD) encompassing the pl range 3-9.5. 
An interelectrode distance of 13 cm was chosen for IgG analysis,  and 11 cm for analysis 
of IgA.  IEF  was  carried out  for 2,400  V.h  for  IgG  and  3,600  V.h  for  IgA.  After 
completion of IEF, the electrode wicks were removed and the portions of the gels where 
IgG and IgA migrated were overlayed with cellulose acetate strips (Sepraphor) containing 
rabbit anti-human  IgG H chain or anti-human  IgA H chain serum (Dako Corp., Santa 
Barbara, CA) at a  1:10 dilution in 50 mM Tris-HCI buffer, pH 7.4, containing 150 mM 
NaCl. The overlay was performed on the cooling plate of the electrophoresis chamber 
thermostatically set to 4°C. After 2 h, the cellulose acetate strips were removed and the 
gel was washed in a total volume of 6 liters of 150 mM NaCl, with several changes over 
24-48 h to remove non-Ig protein. The gel was subsequently processed for silver staining 
using the procedure of Oakley et al. (19). This method permits the detection of IgG and 
IgA in CSF without prior CSF concentration (20). Slab gels with the same ingredients as 
the tube gels  used for 2DE in the O'Farrell procedure (3), were used to analyze IgG L 
chains and IgA and IgM H chains. After IEF, the proteins were transferred from the IEF 
slab  gels  to  nitrocellulose using  the  procedure of Bowen et ai.  (21)  as  described (4). 
Specific L and H chains were then detected by the peroxidase procedure. 
Pur~cation of CSF, Serum,  and Brain IgG,  lgA,  and IgM.  This was done exactly as WALSH  AND  TOURTELLOTTE  43 
FIGURE  1.  IEF gels of CSF obtained from one patient with MS. CSF were obtained in  1974 
and  1982 (a and b, respectively). The procedure of IEF and immunofixation with antibody to 
human lgG H chains followed by silver staining is described in the text. Location of bands (*) 
that are more prominent in lane a  or b. 
described (4). Brain lg were isolated using a modification of the procedure of Hall and 
Choppin (22)  for the  isolation of measles  viral  polypeptides from SSPE  brain;  briefly, 
tissue  was homogenized in 50  mM Tris,  150 mM NaCI  buffer, pH  7.5, containing 1% 
Triton X-100, 1% sodium deoxycholate, and 0.1% SDS, with 5 mM EDTA, 1 mM EGTA, 
4 mM PMSF,  5 mM iodoacetamide, and 20 #M pepstatin A added to inhibit proteolysis. 
The  supernatants  from  a  high  speed  centrifugation  of the  brain  homogenate  were 
incubated with 120 ~1 of a  10% suspension of protein A-Sepharose (PAS) for I2 h on a 
rotator. All procedures were carried out at 0-4°C. The PAS beads were washed exten- 
sively with large volumes of solubilization buffer and the bound proteins were eluted with 
SDS buffer (3) containing 2% DTT; 2DE was carried out as described (3, 4). 
Results 
IEF oflgG and IgA.  Native IEF of IgG was performed on serial CSF obtained 
from 19 patients with clinically definite MS. The intervals over which serial CSF 
were available from individual patients ranged from 7  to  12  yr (mean of 8  yr). 
In  most  of these  19  patients,  the  native  IgG  IEF  spectrotype  was  similar  or 
identical when the first and last available specimens were compared for pattern 
of lgG bands. As shown in Fig.  1, a and b, however, there were some changes in 
spectrotype, although the changes usually represented changes in band intensity 
in  serial  analysis rather  than  loss of major  bands  or acquisition  of major  new 
bands. In some of the  19 MS patients there were considerable temporal changes 
in  CSF  lgG  levels and in  levels of intra-BBB  IgG synthesis (7).  These  changes 
were not reflected in changes in the IgG banding pattern by IEF, nor did changes 
seem more prominent in patients with the greatest quantitative changes in CSF 
IgG. Sonte of the  19 patients had received chemotherapies that caused a  reduc- 
tion  or normalization in  MS  CSF  IgG  levels, as reported  elsewhere (2).  These 
variations in CSF IgG were not reflected in major spectrotype alterations when 
equal amounts of IgG protein were applied to the IEF gels. To further analyze 
the  IgG response  intra-BBB,  CSF IgG was isolated using PAS affinity chroma- 
tography; the IgG was denatured and reduced using lysis buffer (3) and separated 
on  slab  gels;  the  constituent  L  chains  were  then  identified,  after  blotting  to 
nitrocellulose, using the peroxidase technique. It was shown that the stability of 
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L chains. This form of CSF IgG analysis was performed on 6 of the  19 patients. 
Unlike  IgM,  IgA  readily  enters  the  matrix  of polyacrylamide-IEF gels  (LKB 
Instruments,  Inc.);  therefore,  the  procedure  used  to  analyze  native  IgA  was 
identical to that used for IgG analysis except that the CSF sample was applied 2 
cm  from  the  catholyte  and  the  IEF  was  extended  to  3,600  V.h.  The  IgA 
fractionated into ~12  discrete bands;  the spectrotypes were constant in five of 
the six MS patients studied except for minor changes in band intensity (data not 
shown). For native IgA analysis, only the earliest and latest available CSF samples 
were studied;  for  IgG  spectrotype analysis,  yearly CSF,  when  available  from 
individual  patients,  were studied.  Five MS patients  had CSF spectrotypes com- 
pared yearly over as many as 11 yr. Finally, IgA and IgM were isolated by affinity 
chromatography, and the constituent H  chains were separated according to the 
range of pI on slab gels containing 9.4 M urea. Separate immune precipitations 
and slab gel IEF were performed for each Ig class.  The patterns of IgA and IgM 
H  chains were stable in all five patients  studied serially by this technique (data 
not shown). 
2DE oflg Isolated from MS CSF.  Fig. 2 shows the results of analysis of CSF L 
chains by 2DE from the same MS patient shown in Fig.  1. At least 60 spots can 
be detected in the original gel. Although there are changes in intensity of some 
spots in these gels, in this patient, an additional patient (Fig. 2, c and d), and in 
seven other patients studied serially, almost the entire L chain complex of spots 
remained essentially identical or very similar.  By visual inspection, at least 70% 
of the  major  spots were not altered  even  in  patients  studied over >10  yr.  In 
addition to spots on 2DE gels corresponding to intact  H  and  L chains, spots of 
lower M,  (~35,000-40,000  and  ~33,000)  reactive  with  anti-H  chain  antisera 
were usually detected (4).  These spots were at times very prominent and, since 
they were seen on 2DE gels of Ig purified by PAS, they probably contain at least 
the Fc portions of IgG required for binding to protein A. These fragments were 
detected even when CSF was denatured in SDS without prior  lg isolation, and 
their intensity was not reduced with the use of proteolytic inhibitors, suggesting 
that  Ig fragmentation  occurred in vivo (4).  Using the same procedure used for 
IgG, we purified  IgA and IgM from CSF using immunoabsorbents.  Serial CSF 
from three patients  shown to have intra-BBB  IgA and  IgM  synthesis (4) were 
studied this way. As with lgG, the IgA and IgM H chains were fairly similar over 
time (Fig. 3). 
2DE of Ig Isolated from Brain.  Finally,  IgG was isolated from matched CSF, 
sera, and different regions of autologous MS brains.  A total of 11 regions from 
three MS brains were studied; in two cases, the autologous CSF and sera were 
also available for analysis and, in the third patient,  only the autologuous serum 
was studied. We used a solubilization procedure (22) efficient at extracting free 
IgG,  IgG fragments,  and  bound  IgG,  including  immune  complexes, from  the 
brain. Figs. 4 and 5 show the results of 2DE analysis of the purified Ig from one 
MS patient.  First,  IgG and IgM H  chain degradation fragments were prominent 
(data not shown). Second, there were dramatic  differences, in both the L chain 
and in the # chain region, between serum and both autologous CSF and brain- 
extracted Ig, further evidence for a clonally unique immune response intra-BBB 
in  MS (Figs.  4  and  5).  Third,  the  L  chain  pattern  of CSF  IgG obtained  5  yr WALSH  AND  TOURTELLOTTE  45 
FIGURE 2.  2DE of PAS-isolated CSF Ig from the same patient shown in Fig.  I. The L chain 
region is shown. The patterns are nearly identical. Some spots differing in intensity between 
CSF a and b are indicated (*). Specimens a and b were obtained from this patient in 1974 and 
1982, respectively. 2DE of lgG L chains from an MS patient (c and d). Spots that differed in 
intensity between c and d, and unique spots, are indicated (*). Specimens c and d were obtained 
from this patient in  1975 and 1981, respectively. 
FIGURE 3.  2DE of IgM ~ chains isolated from two samples of CSF from a single patient with 
MS, obtained 9  yr apart. A spot that is probably a component of the complement system (4) 
and is prominent in 2DE gels of purified MS CSF Ig, particularly IgM, is shown (*). FIGURE 4.  2DE of lg isolated from control brain (a), lg isolated from four regions of an MS 
brain  (two  sections from  each  cerebral  hemisphere containing one  or  several  plaques  of 
demyelination) (b-e), and of autologous CSF (f) and serum (g). CSF and serum Ig was isolated 
as described (4).  For lg isolation from brain, tissue was solubilized by a  modification of the 
procedure of Hall and Choppin (22)  as described in the text. ~3 g of tissue from each brain 
region was used and the lg was isolated using 120 tal PAS for each affinity purification. Only 
tile  L  chain  regions of the  2DE  gels are  shown. The  L  chain  region  in  b was chosen as 
prototype for comparison with the L chains of CSF and the other three brain regions from 
which IgG was isolated (c-e). The numbers in b indicate prominent L chain spots. The asterisks 
in c-f indicate spots that differ substantially in intensity from the prototype (b). The CSF L 
chain complex shown infis CSF obtained from this patient 5 yr before death. Autolysis time 
for ~he contro~ brain (a) was 18 b, and the amolysis time for the MS brain (c-e) was 12 h. 
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FI(;URt  5.  U chain and a chain region of the 2DE gels (a-f), the L chain portions of which 
are shown in Fig. 4. The location of the lgM and IgA H chains was established by nitrocellulose 
blotting (21). a and fare, respectively,  the matched serum and CSF; (b-e) are the t~ and a 
chain  portions of the  2DE gels of lg isolated  from four regions  of autologous brain;  (b) 
prototype for comparison of the spots in the # chain region (numbered 1-6) in the brain and 
CSF extracts compared with serum.  Despite the differences  in intensity, the major u chain and 
a chain spots are identically located in b-f The ~ chain  region  is remarkably different in b-f 
compared with autologous serum # chains. 
before  the  patient's  death  and  that  of  IgG  extracted  from  four  regions  of 
autologous  brain,  are  similar,  reinforcing  the  view  that  oligoclonal  CSF  IgG 
derives from in situ synthesis by plasma cells in brain, which then diffuses through 
the extracellular  spaces  of the brain  into CSF  (2,  7).  The  greater complexity of 
the brain  L  chains compared  with  autologous CSF, and of both compared with 
most  other  patients  with  MS,  may  be  due  to  the  contamination  of the  brain- 48  MULTIPI,E  SCLEROSIS  lg  BRAIN/SPINAL  FLUID  UNIFORMITY 
extracted IgG with serum IgG derived from cerebral blood vessels,  as well as to 
IgG present in situ due to focal breaks in the BBB in this patient. Fourth, the u 
chain complex of CSF and brain is identical except for quantitative differences, 
and these discrete spots in the # chain region contrast with the normal dispersed 
pI pattern of the autologous serum # chains (Fig. 5). In this patient, no differences 
were seen in the IgA H chains of CSF and brain compared with those of serum, 
although appreciable numbers of IgA-positive plasma cells have been identified 
by  immunocytochemistry in  the  MS  brain  (23)  and  specific  IgA  intra-BBB 
responses are sometimes found in  MS by 2DE (4).  A  similar 2DE pattern was 
observed in the two other MS patients studied in this manner. Finally, because 
it has been reported (8) that IEF patterns of IgG isolated from different regions 
of SSPE brain are more similar to each other than those found in MS, we also 
eluted Ig from three regions of one SSPE brain. A pattern of stability comparable 
to that obtained in the MS brain elution study was seen, although differences in 
the surfaces area occupied by particular spots and in the stain intensity of some 
spots are prominent (Fig.  6),  as illustrated for some L  chain spots of one MS 
patient (Fig. 4). 
Discussion 
The sensitive analytical procedures used in this study collectively establish the 
temporal persistence of clonally homogenous Ig in MS CSF in patients studied 
longitudinally, and establish a relatively uniform distribution of homogenous Ig 
populations throughout individual MS brains. 2DE is the most vivid method to 
demonstrate this uniformity and temporal stability, since discrete silver-stained 
L and H chain spots are defined not only by pI and Mr but by contour and color, 
and are easily compared in different 2DE gels. One important advantage of 2DE 
compared with IEF is its ability to identify spurious pI shifts of homogenous Ig 
that  could  result  from  posttranslational  protein  modifications.  Allotype- and 
idiotype-specific antisera can also be used to measure the presence and persistence 
of structurally unique Ig populations in body fluids and tissues. Measurement of 
allotype levels has indicated (15) a relatively uniform distribution of specific IgG 
allotypes in different regions of individual MS brains. Similarly, idiotype analyses, 
although  failing  to  show  significant  crossidiotypy among  IgG  obtained  from 
different MS patients, indicate (16) a  relatively uniform distribution of specific 
idiotypes in  different regions  of individual  MS  brains.  Idiotype analyses also 
indicate that IgG populations defined by a variety of antiidiotypic reagents persist 
over long periods in  MS  CSF despite flutuations over time (16-18).  It  is  not 
surprising that there are some regional spectrotype differences, however, since 
there are focal breaks in the BBB in MS that contaminate intra-BBB-synthesized 
IgG with serum IgG, as well as regional differences in T  cell populations (24, 
25) that may modulate Ig synthesis by some B cells. Furthermore, when spectro- 
type differences occur as a result of changes in Ig expression at the clonal level, 
such  changes  should  not  be  construed  as  indicative  of change  in  antigenic 
specificity, since it has previously been shown (12,  26),  for example, that the 
antigen-specific SSPE CSF spectrotype is variable in sequential analysis of indi- 
vidual patients. Such changes may merely be a manifestation of factors such as 
cell selection by antigen (27),  maturation of the immune response (27),  cyclic WALSH  AND  TOURTELLOTTE  49 
FIGURE 6.  L chain regions of 2DE gels (a-c) of lg isolated from three regions of one SSPE 
brain; the principal spots correspond in a-c,  but there are differences in  intensity of some 
spots (*), and some of the minor spots are region specific. 
flux in levels of specific antibody production (28), or modulation of Ig synthesis 
by immunoregulatory  T  cells (24,  25).  In  this  context,  it  is extraordinary  that 
the changes we have documented are not greater.  Thus, although  MS CSF and 
brain Ig may represent nonsense antibody, this view is now strongly at variance 
with  2DE,  idiotypic, and  allotypic analysis.  Furthermore,  our failure  to find  a 
major antigen  for intra-BBB-synthesized  Ig in  MS may not relate to nonsense 
antibody production  but  instead  may reflect  the  molecular  complexity of the 
central nervous system and the presumed antigenic target, the myelin membrane 
(4). 
There are other implications  of our results.  Since  MS CSF and brain  IgG is 
pauciclonal but not monoclonal, suppression of humoral immune response using 
an  antiidiotypic  route is not feasible. However, it has never been clearly estab- 
lished whether  MS CSF Ig are  truly demyelinating or cytotoxic to the myelin 
membrane.  In contrast,  it has been established (reviewed in 29) that T  cell lines 
are capable of causing experimental  allergic encephalomyelitis when adoptively 
transferred  into  syngeneic animals;  that  T  cells are  present  at  early  stages  of 
lesion  development,  and  that  T  cellular competence is required  for the devel- 50  MULTIPLE SCLEROSIS  lg  BRAIN/SPINAL FLUID  UNIFORMITY 
opment of the experimental disease.  Recently (30),  antibodies  to  and  cDNA 
probes  for the antigen-specific T  cell  receptor have become available,  cDNA 
probes for Ig genes have already been used to characterize B cell clonal hetero- 
geneity in lymphoproliferative disorders. Cleary et al. (31) have estimated that 
Southern blot analysis is capable of detecting unique B cell rearrangements in B 
cell populations  if such unique rearrangements constitute  1%  or more of the 
total B cell population under study. This is less than the resolving power of 2DE 
for clonal analysis of Ig, but is informative when B cell rearrangements do not 
result in the production of measurable Ig protein. If MS PBL contain relatively 
high levels of T  cells that have undergone unique rearrangements, this should 
now be detectable with cDNA probes and Southern blot hybridization. Similarly, 
the availability of antibodies for the constant regions of the subunits of human 
T  cell receptors should  facilitate  2DE  analysis of the receptor proteins  after 
biosynthetic  labeling.  In  this  way,  a  clonal  characterization  of the  immune 
response at the T  cell level could be accomplished, to determine if immunosup- 
pressive therapy using clonotype-specific anti-T cell antibodies is feasible in MS. 
T  cell clonotype suppression is preferable to pan T  cell suppression, since it is 
likely that prolonged therapy with antibodies for the entire T  helper lymphocyte 
subset would be deleterious. Since we have shown MS CSF and brain Ig to be 
restricted in  complexity, at least at the B cell level, the approaches that have 
resulted in spectacular progress in the molecular characterization of restricted 
mammalian immune responses (e.g., the murine anti-PC response [32]) can now 
be applied to MS. Furthermore, the methods described here should be useful in 
the analysis of other human immune responses characterized by limited diversity 
Ig production. 
Summary 
Elevated cerebrospinal fluid (CSF) IgG and oligoclonal IgG bands on electro- 
phoresis are valuable clinical markers for B cell proliferation in  the brains of 
patients  with  multiple  sclerosis  (MS).  Using  two-dimensional electrophoresis, 
(2DE) we have established that the humoral immune response in  MS  brain  is 
characterized by finite clonal complexity for the major Ig classes.  An important 
question is whether this immune response is clonally stable or varies with time, 
related to the development of new lesions and random entry of B cells into the 
MS brain.  To investigate this,  we performed serial electrophoretic studies on 
CSF obtained from 19 patients with MS; the intervals ranged from 7  to  12 yr, 
with a mean of 8 yr. These analyses included studies of IgG, IgA, and IgM, and 
revealed that the humoral immune response in  MS is clonally stable over long 
periods. Spontaneous fluctuations or reduction in CSF IgG levels by drugs did 
not qualitatively affect B cell clonal proliferation in MS brain, in that dominant 
bands and spots were not obliterated. It has been asserted that IgG synthesis in 
MS is nonsense antibody because the spectotypes of IgG isolated from different 
regions  of  MS  brains  differ.  Factors  other  than  clonal  heterogeneity could 
account  for  differences  found  using  one-dimensional  analysis.  B  cell  clonal 
products  resolve into  unique  and  well-resolved spots  by  2DE;  the  method is 
uniquely suitable for analysis of restricted immune responses. Therefore, Ig were 
isolated from 11 regions of three MS brains and the 2DE patterns were compared. WALSH AND  TOURTELLOTTE  51 
The similarity of the 2DE patterns indicate unequivocally that major clones are 
distributed uniformly although some clones are more prominent in some brain 
areas.  IgA and  IgM  isolated from the same areas also showed similar patterns. 
Furthermore,  the patterns  of light and  heavy chains  in  brain  regions differed 
from serum  but  were similar  to  the  autologous CSF,  providing new  evidence 
that CSF IgG in MS derives from synthesis in situ. Our results indicate that, once 
initiated,  B  cell  clonal  proliferation  persists  indefinitely  and  is  little  altered 
qualitatively at a clonal level over time, even when CSF IgG levels change or are 
altered by drugs.  Our results are consistent with allotype and  idiotype analysis 
of Ig  production  in  MS and  conflict with  nonsense  antibody proposals of the 
origin and nature of in situ synthesized Ig in MS. 
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